An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer’s disease pathology following closed head injury: Evidence of pharmacogenomic interaction

Aono, 2003, Protective effect of apolipoprotein E-mimetic peptides on N-methyl-D-aspartate excitotoxicity in primary rat neuronal-glial cell cultures, Neuroscience, 116, 437, 10.1016/S0306-4522(02)00709-1 Barger, 1997, Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E, Nature, 388, 878, 10.1038/42257 Bramlett, 1997, Temporal and regional patterns of axonal damage following traumatic brain injury: a beta-amyloid precursor protein immunocytochemical study in rats, J Neuropathol Exp Neurol, 56, 1132, 10.1097/00005072-199710000-00007 Brown, 2002, Apolipoprotein E isoform mediated regulation of nitric oxide release, Free Radic Biol Med, 32, 1071, 10.1016/S0891-5849(02)00803-1 Buttini, 2000, Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease, Neuroscience, 97, 207, 10.1016/S0306-4522(00)00069-5 Chen, 1997, Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury, Neuroscience, 80, 1255, 10.1016/S0306-4522(97)00007-9 Colton, 2001, Apolipoprotein E acts to increase nitric oxide production in macrophages by stimulating arginine transport, Biochim Biophys Acta, 1535, 134, 10.1016/S0925-4439(00)00092-2 Colton, 2002, Apolipoprotein-E allele-specific regulation of nitric oxide production, Ann N Y Acad Sci, 962, 212, 10.1111/j.1749-6632.2002.tb04070.x Colton, 2004, APOE genotype-specific differences in human and mouse macrophage nitric oxide production, J Neuroimmunol, 147, 62, 10.1016/j.jneuroim.2003.10.015 Corder, 1993, Gene doses of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families, Science, 261, 921, 10.1126/science.8346443 de Bont, 1999, AFJ Lipid Res, 40, 680, 10.1016/S0022-2275(20)32147-7 Dommergues, 2003, Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection, Neuroscience, 121, 619, 10.1016/S0306-4522(03)00558-X Egensperger, 1998, Microglial activation in Alzheimer disease: Association with APOE genotype, Brain Pathol, 8, 439, 10.1111/j.1750-3639.1998.tb00166.x Esler, 2001, A portrait of Alzheimer secretases: new features and familiar faces, Science, 293, 1449, 10.1126/science.1064638 Foda, 1994, A new model of diffuse brain injury in rats, J Neurosurg, 80, 301, 10.3171/jns.1994.80.2.0301 Friedman, 1999, Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury, Neurology, 52, 244, 10.1212/WNL.52.2.244 Hamm, 1994, The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury, J Neurotrauma, 11, 187, 10.1089/neu.1994.11.187 Horsburgh, 2000, Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia, Eur J Neurosci, 12, 4309 Huang, 2001, Apolipoprotein E fragments present in Alzheimer’s disease brains induce neurofibrillary tangle-like inclusions in neurons, Proc Natl Acad Sci U S A, 98, 8838, 10.1073/pnas.151254698 Jordan, 1997, Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing, JAMA, 278, 136, 10.1001/jama.1997.03550020068040 Laskowitz, 1997, Apolipoprotein E suppresses glial cell secretion of TNFα, J Neuroimmunol, 76, 70, 10.1016/S0165-5728(97)00021-0 Laskowitz, 1998, Apolipoprotein E and the CNS response to injury, J Cereb Blood Flow Metab, 18, 465, 10.1097/00004647-199805000-00001 Laskowitz, 1998, Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production, Neuroreport, 9, 615, 10.1097/00001756-199803090-00010 Laskowitz, 2000, Altered immune responses in apolipoprotein E-deficient mice, J Lipid Res, 41, 613, 10.1016/S0022-2275(20)32409-3 Laskowitz, 2001, Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides, Exp Neurol, 167, 74, 10.1006/exnr.2001.7541 Linton, 1991, Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation, J Clin Invest, 81, 270, 10.1172/JCI115288 Lynch, 2001, Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response, J Neuroimmunol, 114, 107, 10.1016/S0165-5728(00)00459-8 Lynch, 2002, Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema, Ann Neurol, 51, 113, 10.1002/ana.10098 Lynch, 2003, APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response, J Biol Chem, 278, 48529, 10.1074/jbc.M306923200 Lynch, 2005, A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury, Exp Neurol, 192, 109, 10.1016/j.expneurol.2004.11.014 Marmarou, 1994, A new model of diffuse brain injury in rats, J Neurosurg, 80, 291, 10.3171/jns.1994.80.2.0291 McAdoo, 2005, Intrathecal administration of a novel apoE-derived therapeutic peptide improves outcome following perinatal hypoxic-ischemic injury, Neurosci Lett, 381, 305, 10.1016/j.neulet.2005.02.036 McCarron, 2003, Effect of apolipoprotein E genotype on in-hospital mortality following intracerebral haemorrhage, Acta Neurol Scand, 107, 106, 10.1034/j.1600-0404.2003.01365.x Misra, 2001, Apolipoprotein E and mimetic peptide initiate a calcium-dependent signaling response in macrophages, J Leukoc Biol, 70, 677, 10.1189/jlb.70.4.677 Nicoll, 1995, Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury, Nat Med, 1, 135, 10.1038/nm0295-135 Ott, 1994, Cytokines and metabolic dysfunction after severe head injury, J Neurotrauma, 11, 447, 10.1089/neu.1994.11.447 Roselaar, 1998, Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo, J Lipid Res, 39, 740, 10.1016/S0022-2275(20)32160-X Sabo, 2000, Susceptibility of transgenic mice expressing human apolipoprotein E to closed head injury: the allele E3 is neuroprotective whereas E4 increases fatalities, Neuroscience, 101, 879, 10.1016/S0306-4522(00)00438-3 Schiefermeier, 2000, Apolipoprotein E polymorphism: survival and neurological outcome after cardiopulmonary resuscitation, Stroke, 31, 2068, 10.1161/01.STR.31.9.2068 Schmued, 2000, Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration, Brain Res, 874, 123, 10.1016/S0006-8993(00)02513-0 Selkoe, 2001, Alzheimer’s disease: genes, proteins, and therapy, Physiol Rev, 81, 741, 10.1152/physrev.2001.81.2.741 Sheng, 1998, Apolipoprotein E isoform specific differences in outcome from focal ischemia in transgenic mice, J Cereb Blood Flow Metab, 18, 361, 10.1097/00004647-199804000-00003 Sorbi, 1995, ApoE as a prognostic factor for post-traumatic coma, Nat Med, 1, 852, 10.1038/nm0995-852 Sullivan, 1997, Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis, Biol Chem, 227, 17972, 10.1074/jbc.272.29.17972 Teasdale, 1997, Association of apolipoprotein E polymorphism with outcome after head injury, Lancet, 350, 1069, 10.1016/S0140-6736(97)04318-3 Uryu, 2002, Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis, J Neurosci, 22, 446, 10.1523/JNEUROSCI.22-02-00446.2002 Vitek, 1997, Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide, Biochem Biophys Res Commun, 240, 391, 10.1006/bbrc.1997.7408 Weisgraber, 1994, Apolipoprotein E structure-function relationships, Adv Protein Chem, 45, 249, 10.1016/S0065-3233(08)60642-7 West, 1991, Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator method, Anat Rec, 231, 482, 10.1002/ar.1092310411 West, 1996, Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method, J Comp Neurol, 370, 11, 10.1002/(SICI)1096-9861(19960617)370:1<11::AID-CNE2>3.0.CO;2-O